Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado, a body”

255 pharma patents match "The Regents of the University of Colorado, a body" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 255
Index total 30,257
Page 10 / 11

Quick answer

This filtered view shows 255 pharmaceutical patents matching "The Regents of the University of Colorado, a body" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

255 results for “The Regents of the University of Colorado, a body” · 30,257 patents in full index Clear search

  1. US 8816046

    Compositions and methods for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  2. US 8808710

    Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  3. US 8735358

    Methods for treating cancer by regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted May 27, 2014 · Expires May 22, 2034

    granted

  4. US 8727775

    Dimer acid-derived dimethacrylates and use in dental restorative compositions

    The Regents of the University of Colorado, a Body Corporate · Granted May 20, 2014 · Expires May 15, 2034

    granted

  5. US 8725266

    Method for stimulating retinal response using photoactive devices

    The Regents of the University of Colorado, a Body Corporate · Granted May 13, 2014 · Expires May 8, 2034

    granted

  6. US 8715649

    Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity

    The Regents of the University of Colorado, a Body Corporate · Granted May 6, 2014 · Expires May 1, 2034

    granted

  7. US 8703140

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  8. US 8697628

    Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  9. US 8685926

    Compositions and method for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  10. US 8673300

    Therapeutic compositions and methods for the prevention of autoimmune diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  11. US 8652475

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  12. US 8642614

    Toll-like receptor modulators and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  13. US 8637239

    Minimally-invasive measurement of esophageal inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  14. US 8623917

    Uses of prostacyclin analogs

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  15. US 8598133

    Methods for treating pain

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  16. US 8575170

    Flurbiprofen analogs and methods of use in treating cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  17. US 8569225

    Targeting complement factor H for treatment of diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  18. US 8563515

    Tight junction protein modulators and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  19. US 8557764

    Methods of modulating immune function

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  20. US 8540997

    Complement receptor 1 and 2 fusion proteins

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted

  21. US 8524678

    Method for delivering genes

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted

  22. US 8454977

    Non-toxic biofilm inhibitor

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  23. US 8444991

    Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

    The Regents of the University of Colorado, a Body Corporate · Granted May 21, 2013 · Expires May 16, 2033

    granted

  24. US 8404650

    Methods of treating cancer with doxazolidine and prodrugs thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.